DrugDashboards

Efavirenz

Efavirenz · EFAVIRENZ 100 mg/1 · Capsule · Oral · Aurobindo Pharma Limited

NDC 65862-0105-10 · 3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for efavirenz (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA078064
TE code
Approval date
Dec 15, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Efavirenz (Capsule)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedEFAVIRENZ 100 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedEFAVIRENZ 200 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedEFAVIRENZ 50 mg/1Jul 15, 2026Sep 3, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Efavirenz — NDC 65862-0105-10," retrieved September 3, 2026, https://drugdashboards.com/drug/65862010510.

Free to cite with attribution — see how the data is put together.